BSP team identifies cost savings for hospitals treating SIRS patients; results to be released at ASHP Midyear Clinical Meeting 2014

//platform.linkedin.com/in.js Anaheim, California: Treating systemic inflammatory response syndrome (SIRS) afflicted hospitalized patients with balanced calcium-free intravenous crystalloid solutions (solutions of mineral salts or other water-soluble molecules) can save a 300-bed hospital as much as $2.77 million over 5 years according…

BSP collaborative meta-analysis identifies association between the use of high-chloride intravenous crystalloid fluids and unfavorable patient outcomes in the perioperative or intensive care setting

//platform.linkedin.com/in.js A significant association between the use of high-chloride intravenous crystalloid fluids and unfavorable patient outcomes in the perioperative or intensive care setting has been discovered by a team of researchers including Dr. Scott Paluszkiewicz of Boston Strategic Partners, Inc…

BSP President Fabian D'Souza Advises International Seminar at AdvaMed 2014

//platform.linkedin.com/in.js Chicago, Illinois: Boston Strategic Partners, Inc. (BSP) President Fabian D'Souza was invited as a panelist at the recently concluded International Seminar at AdvaMed 2014. The International Seminar was organized exclusively for the international delegations attending AdvaMed 2014 to address principal…

BSP collaborative research identifies association between administered intravenous chloride load and in-hospital mortality rate in patients with SIRS

//platform.linkedin.com/in.js Limiting the amount of chloride administered via intravenous fluids to patients with systemic inflammatory response syndrome (SIRS) may lower their in-hospital mortality rate according to a study by a team which included Boston Strategic Partners, Inc. (BSP) researchers.  The…

BSP addresses the biophotonics industry at the Strategies in Biophotonics 2014 Conference

//platform.linkedin.com/in.js Boston, MA: Boston Strategic Partners, Inc. (BSP) executives Dr. Fabian D'Souza, President, Dr. Fred Peyerl, Partner, and Dr. Sibyl Munson, Principal, delivered presentations at the recently concluded Strategies in Biophotonics Conference 2014 organized between September 9-11, 2014. Strategies in Biophotonics…